Literature DB >> 16177404

Postbiopsy splenic bleeding in a dog model: comparison of cauterization, embolization, and plugging of the needle tract.

Seung Hong Choi1, Jeong Min Lee, Kyoung Ho Lee, Se Hyung Kim, Jae Young Lee, Joon Koo Han, Byung Ihn Choi.   

Abstract

OBJECTIVE: The purpose of our study was to compare radiofrequency cauterization, embolization using an absorbable gelatin sponge, and a Histoacryl-Lipiodol mixture plugging as postbiopsy bleeding reduction methods after splenic core needle biopsy in a dog model.
MATERIALS AND METHODS: Eleven mongrel dogs were randomly separated into nonheparinized (n = 5) and heparinized (n = 6) groups. Eight splenic biopsies per animal were performed using an 18-gauge automated core biopsy needle: two as controls, two ablated by radiofrequency, two embolized using an absorbable gelatin sponge, and two plugged using a Histoacryl-Lipiodol mixture. Procedure times and postbiopsy bleeding amounts were assessed. Statistically significant differences were determined by repeated measures analysis of variance; the Tukey-Kramer test for multiple comparisons was used for post hoc comparisons. Three-day follow-up CT scans were obtained to check for procedure-related complications or delayed bleeding.
RESULTS: The postbiopsy bleeding reduction groups showed significantly less blood loss than the control group for both the nonheparinized (p < 0.0001) and heparinized groups (p < 0.0001). In the heparinized group, both radiofrequency cauterization (p < 0.01) and gelatin sponge embolization (p < 0.05) significantly reduced bleeding compared with Histoacryl-Lipiodol mixture plugging. Gelatin sponge embolization was the longest procedure (p < 0.001). On follow-up CT, no delayed bleeding was observed. However, multiple Histoacryl-Lipiodol emboli were observed in the splenic and portal veins in all the dogs we treated.
CONCLUSION: Radiofrequency cauterization was found to be the most useful postbiopsy bleeding reduction method in terms of the amount of bleeding and the procedure time.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177404     DOI: 10.2214/AJR.04.1395

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

Review 1.  Image-guided percutaneous splenic biopsy and drainage.

Authors:  Jennifer Sammon; Maria Twomey; Lee Crush; Michael M Maher; Owen J O'Connor
Journal:  Semin Intervent Radiol       Date:  2012-12       Impact factor: 1.513

2.  Embolization of percutaneous transhepatic portal venous access tract with N-butyl cyanoacrylate.

Authors:  S Y Park; J Kim; B W Kim; H J Wang; S S Kim; J Y Cheong; S W Cho; J H Won
Journal:  Br J Radiol       Date:  2014-07-16       Impact factor: 3.039

Review 3.  Diagnosis and management of hemorrhagic complications of interventional radiology procedures.

Authors:  Mark L Lessne; Brian Holly; Steven Y Huang; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

4.  Portal vein recanalization and embolization of the transsplenic puncture tract using an Amplatzer® vascular plug: a case report.

Authors:  Ulrich Grosse; Klaus Brechtel; Dominik Ketelsen; Roland Syha; Gerd Grözinger; Fabian Springer; Christoph Thomas
Journal:  BMC Res Notes       Date:  2015-05-08

Review 5.  Clinical application of partial splenic embolization.

Authors:  Yong-Song Guan; Ying Hu
Journal:  ScientificWorldJournal       Date:  2014-11-03

6.  New Radiofrequency Device to Reduce Bleeding after Core Needle Biopsy: Experimental Study in a Porcine Liver Model.

Authors:  Sanghyeok Lim; Hyunchul Rhim; Min Woo Lee; Kyoung Doo Song; Tae Wook Kang; Young-Sun Kim; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2017-01-05       Impact factor: 3.500

7.  Safety and efficacy of percutaneous microwave ablation for post-procedural haemostasis: a bi-central retrospective study focusing on safety and efficacy.

Authors:  Tian'an Jiang; Alexis Kelekis; Qiyu Zhao; Argyro Mazioti; Jia Liu; Nikolaos Kelekis; Guo Tian; Dimitrios Filippiadis
Journal:  Br J Radiol       Date:  2019-12-12       Impact factor: 3.039

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.